Delayed Graft Function

Download PDF

Recent Publications on Delayed Graft Function:
Partial Recovery of Delayed Graft Function due to Cholesterol Emboli after Renal Transplantation. A 65-year-old man who received a deceased renal allograft in September...	27th June, 2008	Department of Nephrology, Transplantation and Peritoneal Dialysis,	Saudi J Kidney Dis Transpl. 2008 Jul-Aug;19(4):631-5.
Sirolimus use in recipients of expanded criteria donor kidneys. With changing donor characteristics and the growing shortage in organ...	24th June, 2008	University of Western Ontario Faculty of Medicine, London, Ontario,	Drugs. 2008;68 Suppl 1:41-9.
Long-term renal outcomes after delayed graft function. Delayed graft function (DGF) describes dysfunction of the kidney allograft...	21st June, 2008	Department of Medicine, Section of Nephrology, Yale School of Medicine,	Adv Chronic Kidney Dis. 2008 Jul;15(3):248-56. DOI Direct Link
Impact of cold ischemia time on renal allograft outcome using kidneys from young donors. Prolonged cold ischemia time (CIT) is associated with delayed graft...	21st June, 2008	Department of Nephrology and Research Unit, Hospital Universitario de	Transpl Int. 2008 Jun 18;. DOI Direct Link
Acute Tubular Injury in Protocol Biopsies of Renal Grafts: Prevalence, Associated Factors and Effect on Long-Term Function. Acute tubular injury (ATI) is commonly observed in renal allografts,...	19th June, 2008	Division of Nephrology, Department of Internal Medicine, Medical School	Am J Transplant. 2008 Jun 12;. DOI Direct Link
→View more research publications.

BioNews Results for Delayed Graft Function:
Quark Pharmaceuticals Receives FDA Approval of IND for Kidney Transplant siRNA Drug DGFi	Pharma Live:  Jun 26 2008 9:25AM Matching: delayed graft function
Quark Pharmaceuticals Receives FDA Approval of IND for Kidney Transplant siRNA Drug DGFi	Business Journal of Milwaukee:  Jun 25 2008 1:00PM Matching: delayed graft function
Quark Pharmaceuticals Receives FDA Approval of IND for Kidney Transplant siRNA Drug DGFi	Cincinnati Business Journal:  Jun 25 2008 12:20PM Matching: delayed graft function
Quark Pharmaceuticals Receives FDA Approval of IND for Kidney Transplant siRNA Drug DGFi	Columbus Business First:  Jun 25 2008 12:11PM Matching: delayed graft function
Quark Pharmaceuticals Receives FDA Approval of IND for Kidney Transplant siRNA Drug DGFi	San Antonio Business Journal:  Jun 25 2008 12:09PM Matching: delayed graft function
Promote your company here: BioNewsCast - Press Release Distribution	→View more news.

Delayed Graft Function Clinical Trials:
Effect of Procrit(Epoetin Alfa) on Preventing Delayed Graft Function After Deceased Donor Renal Transplantation	Delayed Graft Function
Study of Enteric-Coated Mycophenolate Sodium (EC-MPS) Plus Reduced-Dose Cyclosporine Microemulsion (CsA-ME) Compared to EC-MPS Plus Standard Dose CsA-ME in Eldery de Novo Renal Transplant Recipients Treated With Basiliximab and Short-Term Steroids	De Novo Renal Transplantation
Organ Preservation Media Investigation	Kidney Transplant
Safety and Tolerability Study of Inhaled Carbon Monoxide in Kidney Transplant Patients	Kidney Transplantation
MMF, Daclizumab and Corticosteroids as Mainstay Immunosuppression in Renal Transplant Patients	Kidney Transplantation
→View more trials.

Delayed Graft Function Patents:
US Patent No.	Title
7364734	Treatment of LFA-1 associated disorders with increasing doses of LFA-1 antagonist
6897225	Inhibitors of .alpha.L.beta.2 mediated cell adhesion
6894155	Nucleic acid molecules and polypeptides for immune modulation
6803384	Diaminopropionic acid derivatives
6784154	Method of use of erythropoietin to treat ischemic acute renal failure
→View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Delayed Graft Function scientists - we have details of around 114 individuals working on Delayed Graft Function .

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.